Related Experiment Video
Updated: Apr 28, 2026

Metabolic Pathway Confirmation and Discovery Through 13C-labeling of Proteinogenic Amino Acids
Published on: January 26, 2012
GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples
Arslan Arinc Kayacelebi1, Bibiana Beckmann, Frank-Mathias Gutzki
1Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Insights
L-Homoarginine (hArg) is a cardiovascular risk factor. New GC-MS and GC-MS/MS methods accurately quantify hArg in human plasma, urine, and sputum, aiding its study in health and disease.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Clinical Chemistry
Background:
- L-Homoarginine (hArg) is recognized as a novel cardiovascular risk factor.
- Elevated hArg levels are associated with a poor prognosis in heart failure patients.
- Accurate quantification methods are needed to study hArg's role in human physiology and pathology.
Purpose of the Study:
- To develop and validate robust gas chromatography-mass spectrometry (GC-MS) and GC-MS/MS methods.
- To enable the quantitative determination of hArg in diverse biological samples.
- To assess hArg concentrations in human plasma, urine, and sputum.
Main Methods:
- Development of GC-MS and GC-MS/MS assays for hArg quantification.
- Use of derivatization with methyl ester tri(N-pentafluoropropionyl).
- Employing deuterated hArg or labeled arginine as internal standards and electron-capture negative-ion chemical ionization.
Main Results:
- Validated GC-MS and GC-MS/MS methods provide accurate and precise hArg quantification.
- Similar hArg concentrations were obtained using both GC-MS and GC-MS/MS.
- Plasma and serum hArg levels were comparable, indicating minimal preanalytical variation.
- Creatinine-corrected urinary hArg excretion in healthy subjects showed considerable variability.
- A positive correlation was observed between urinary hArg and ADMA levels.
Conclusions:
- GC-MS is a suitable method for accurate hArg quantification in biological samples.
- The developed methods are valuable tools for investigating hArg's physiological and pathological roles.
- hArg is present at approximately 2 µM in human plasma and may be a component of plasma proteins.
Abstract:
L-Homoarginine (hArg) has recently emerged as a novel cardiovascular risk factor and to herald a poor prognosis in heart failure patients. Here, we report on the development and thorough validation of gas chromatography-mass spectrometry (GC-MS) and gas chromatography-tandem mass spectrometry (GC-MS/MS) methods for the quantitative determination of hArg in biological samples, including human plasma, urine and sputum. For plasma and serum samples, ultrafiltrate (10 µL; cutoff, 10 kDa) was used. For urine samples, native urine (10 µL) was used. For sputum, protein precipitation by acetone was performed. hArg is derivatized to its methyl ester tri(N-pentafluoropropionyl) derivative; de novo synthesized trideutero-methyl ester hArg is used as the internal standard (IS). Alternatively, [guanidino-(15)N2]-arginine can be used as an IS. Quantitative analyses were performed after electron-capture negative-ion chemical ionization by selected-ion monitoring in GC-MS and selected-reaction monitoring in GC-MS/MS. We obtained very similar hArg concentrations by GC-MS and GC-MS/MS, suggesting that GC-MS suffices for accurate and precise quantification of hArg in biological samples. In plasma and serum samples of the same subjects very close hArg concentrations were measured. The plasma-to-serum hArg concentration ratio was determined to be 1.12 ± 0.21 (RSD, 19 %), suggesting that blood anticoagulation is not a major preanalytical concern in hArg analysis. In healthy subjects, the creatinine-corrected urinary excretion of hArg varies considerably (0.18 ± 0.22 µmol/mmol, mean ± SD, n = 19) unlike asymmetric dimethylarginine (ADMA, 2.89 ± 0.89 µmol/mmol). In urine, hArg correlated with ADMA (r = 0.475, P = 0.040); in average, subjects excreted in the urine about 17.5 times more ADMA than hArg. In plasma of healthy humans, the concentration of hArg is of the order of 2 µM. hArg may be a low-abundance constituent of human plasma proteins. The GC-MS and GC-MS/MS methods we report in this article are useful to study the physiology and pathology of hArg in experimental and clinical settings.
More Related Videos
11:06GC-based Detection of Aldononitrile Acetate Derivatized Glucosamine and Muramic Acid for Microbial Residue Determination in Soil
Published on: May 19, 2012
08:06Absolute Quantification of Cell-Free Protein Synthesis Metabolism by Reversed-Phase Liquid Chromatography-Mass Spectrometry
Published on: October 25, 2019
Related Concept Videos
Gas Chromatography–Mass Spectrometry (GC–MS)
A gas chromatograph consists of a long, narrow capillary column with a polysiloxane coating on the inner wall....
Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...